| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/26/2006 | CN1764640A Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with nitro compounds |
| 04/26/2006 | CN1764639A Preparing method of N-(methyl-aryl)-2-lactam, N-(methyl cycloaklyl)-2-lactam and n-alkyl-2-lactam |
| 04/26/2006 | CN1764638A Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5- methyl-N-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with cyano compou |
| 04/26/2006 | CN1764451A Method for preparing 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone |
| 04/26/2006 | CN1764449A Preparing method of 5-methyl-N-aryl-2-pyrrolidone and 5- methyl-N-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines |
| 04/26/2006 | CN1764379A Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone |
| 04/26/2006 | CN1764378A Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 04/26/2006 | CN1764377A Preparing method of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 04/26/2006 | CN1764376A Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 04/26/2006 | CN1763004A Method of separating imide compound |
| 04/26/2006 | CN1763002A Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 04/26/2006 | CN1762993A Chiral sulfonamide-aminol ligand and preparation method and uses |
| 04/26/2006 | CN1762989A Semicarbazone synthesis method |
| 04/26/2006 | CN1253554C acidophilic bacteria strain with nitrile hydrolase activity |
| 04/25/2006 | US7034164 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 04/25/2006 | US7034163 From alkoxycyclopropane with nitrile in presence of Lewis acid catalyst |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034051 Fused bicyclic carboxamide derivatives and methods of their use |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | CA2522899C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521956C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1-h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521908C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521891C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521887C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521833C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521828C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521792C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521776C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/20/2006 | WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/20/2006 | WO2006040192A1 Pyrrolidine derivatives as histamine receptors ligands |
| 04/20/2006 | WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040179A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006018708A3 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 04/20/2006 | WO2005096734A3 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/20/2006 | WO2005067446A3 Composition and method for preventing fouling in (meth)acrylic acid processes |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084816 Process for the production of atorvastatin calcium |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084634 treatment of gram positive, gram negative and antibiotic resistant infections; [4(R,S)-(4a alpha ,5a alpha ,12a alpha )]-4-(Dimethylamino)-7-(1H-Tetrazol-1-yl)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide |
| 04/20/2006 | US20060084612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 04/20/2006 | CA2583983A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583918A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583457A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/19/2006 | EP1647546A1 Novel heteroaryl derivative |
| 04/19/2006 | EP1646661A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/19/2006 | EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/19/2006 | EP1646626A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646625A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1383736A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1383729A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1097152B1 Synthesis of compounds useful in the manufacture of ketorolac |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761667A 3-phenyl substituted 3-substituted-4ketolactams and ketolactones |
| 04/19/2006 | CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 04/19/2006 | CN1761650A Compounds, a process for their preparation and their use as dyes and pigments |
| 04/19/2006 | CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 04/19/2006 | CN1761645A Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 04/19/2006 | CN1252055C Biphenyl carboxamides compounds |
| 04/19/2006 | CN1252053C Method for synthesizing N-substitution pyrrole in ion liquid |
| 04/19/2006 | CN1252052C Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 04/19/2006 | CN1252051C Positron emitted computerized tomography imaging agent benzamide derivative synthesizing method |
| 04/19/2006 | CN1252042C Oximate light initiator |
| 04/19/2006 | CN1252038C New derivatives of substituted anilines with herbicidal activity |
| 04/18/2006 | US7030249 Amination, hydrogenation with hydrogen in presence of a metal catalyst to produce 1,5-dimethyl-2-pyrrolidone; catalyst support; stability, efficiency; use as cleaners, solvents, surfactants, dispersants, detergents and emulsifiers |
| 04/18/2006 | US7030201 of a polymer containing units of an imide-substituted acrylate type monomer and a crosslinking agent; making the monomer by reacting glycidyl methacrylate and succinimide for example; useful in making semiconductor devices by photolithographic techniques, improved etch-rate |
| 04/18/2006 | US7030151 Micronized amorphous form for better bioavailability; hypercholesterolemia, hyperlipidemia |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030116 Compounds and compositions as cathepsin inhibitors |
| 04/18/2006 | US7030114 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/18/2006 | US7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 04/18/2006 | US7030074 Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006038989A1 Substituted arylamides |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038119A1 Stereoselective synthesis of n-protected alkoxy prolines |
| 04/13/2006 | WO2006037775A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 04/13/2006 | WO2006037761A1 New histone deacetylases inhibitors |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy |
| 04/13/2006 | DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers |
| 04/13/2006 | DE102004047255A1 Prolinderivate Proline |
| 04/12/2006 | EP1645556A1 Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents |
| 04/12/2006 | EP1644334A1 Antithrombotic ethers |
| 04/12/2006 | EP1644327A1 Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome |
| 04/12/2006 | EP1644325A2 Methods and compositions for treating amyloid-related diseases |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |
| 04/12/2006 | EP1643986A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1495015B1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |